J. Griffiths

Domain binding and isotype dictate the activity of anti-human OX40 antibodies

M. Cragg, M. Glennie, R. French, 2020, Journal for ImmunoTherapy of Cancer.

Domain binding and isotype dictate the activity of anti-human OX40 antibodies

M. Cragg, M. Glennie, A. Tutt, 2020, Journal for ImmunoTherapy of Cancer.

Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking

M. Cragg, M. Glennie, R. French, 2018, Scientific Reports.

OX40: Structure and function - What questions remain?

M. Cragg, I. Tews, J. Willoughby, 2017, Molecular immunology.